DEERFIELD, DISEASE – (– Baxter International Inc. (NYSE: BAX), a global breakthrough in kidney care, has nearly doubled the survival rate of kidney patients and revealed long-term adverse events (AE) and hospitalization. When Share source Remote Patient Management Digital Health Platform is used to manage automated peritoneal decontamination (APD) at home.1

The new data was presented by the American Nephrology Association’s annual Kidney Week, November 4-7, in a draft session.Removal monitoring of APD patients may improve clinical outcomes by analysis of competitive risk recovery models” [PO0965]. A randomized controlled trial of 815 kidney patients covering 22 hospitals in Mexico assessed the death and admission of first AE or first hospital patients with remote patient management digital health and at home APD.

“The study indicates Sharesource’s It plays a key role in supporting clinically significant outcomes that help kidney patients access home cleaning and stay on treatment as long as possible, ”said Peter Rutherford, MB BS, PhD, Vice President of Medical Affairs, Baxter Renal Care. “As we move forward with the Covide-19 epidemic, it is demonstrating how digital healthcare professionals can improve clinical outcomes and keep patients at home in unexpected hospital visits.”

Share source Remote Patient Management allows healthcare professionals to monitor their patients’ home hygiene and adjust patients to remote clinics without having to visit the clinic without a plan. Share source Widespread housekeeping is a digital health platform. It is used to care for almost 50% of all patients on Bacteria’s APD systems worldwide. The Digital Health Forum is available in more than 70 countries and has administered more than 32 million treatments to date.

Supporting broad international acceptance Share source Remote patient management is evidence of early detection and intervention of health care providers in catheter cases.2, 3, 4, 5 peritonitis,6 And control-related problems;7,8,9 It can lead to a reduction in hospitals.10

The new study was conducted with> 100 exposed and> 50 new patients serving hospitals and> hospitals with 5 years of APD experience. 22 Hospitals are randomly assigned to operate remote patient management with APD or equivalent APD equipment. The study followed a total of 815 patients — 417 using remote patient management and 398 with normal APD – for at least one year.

Patients using only normal APD in the study had significantly higher mortality of all causes (sHR 1.79, 95% CI (1.15–2.81); p = 0.01), CV-related mortality (sHR2.21, 95% CI (1.07-4.58); p = 0.03) and AE (sHR 1.74, 95% (1.34–2.25); p = 0.001) compared with patients using APD with remote patient management. The data show that the use of remote patient management improves recovery and prolongs hospital stay with those who use only AE and APD alone, and digital health may improve the clinical outcomes of APD patients.

About the peritoneal dialysis

People with advanced kidney disease need dialysis treatment or kidney transplant to survive. PD therapy is usually administered at home to patients during the day. It works by cleansing the blood of toxins and removing extra fluids in the peritoneal cavity. Studies show that patients and physicians often prefer home cleaning.11 PD patients receive improved early survival and higher levels of satisfaction and quality of life.12,13,14

About Backster

Every day, millions of patients and caregivers rely on Baxter Leader’s critical care, nutrition, kidney, hospital and surgical products. We have been working at a critical juncture where we can connect with healthcare providers that will save and sustain life for 90 years. With products, technologies and treatments in more than 100 countries, Bucster’s employees around the world are building on the company’s rich medical innovations to promote next-generation dynamic healthcare innovations. To learn more, visit www.baxter.com And follow us. Twitter, LinkedIn And Facebook.

Rx only. For complete and correct use of this tool, see the complete instructions for use.

This release includes forward-looking statements about the case Share source Remote Patient Management Forum, including possible benefits associated with its use. The statements are based on assumptions about many important factors, including the fact that the actual results may differ materially from future statements: demand and market acceptance of new and existing products; Product development hazards; Failure to create additional production capacity on time or other manufacturing or supply problems (public health crises and epidemics due to natural disasters, control measures or other) satisfaction of regulatory and other requirements; Actions of regulators and other government officials; Product quality, product or supply, or patient safety issues; Changes in laws and regulations; And other concerns identified in Baxter’s most recent Form 10-K and other SEC documents, all available on Baxter’s website. Buxter did not work to update future statements.

Baxter and Share source Baxter International Inc. is a registered trademark.


1 Pania R, et al. Summary of ASN Kidney Week 2021. Imaginary. 2021. [PO0965]

2 Jiménez S & Condia J. Abstract presented at the 17th ISPD Congress. Vancouver (Canada). 2018. [P-337]

3 Garcia I, et al. Briefing at the 13th Euro-PD Congress. Dublin (Ireland) 2017. [P-63]

4 Joternand Draper V, et al. Presentation at the ASN Kidney Week Congress. Chicago (USA) 2016. [SA-PO023]

5 Rojas-Diaz M., et al. Presentation at the ASN Kidney Week Congress. New Orleans (USA) 2017. [PUB344]

6 Gomez R., et al. A briefing was presented at the 13th Euro-PD Congress. Dublin (Ireland) 2017. [P-222]

7 Jiménez S & Condia J. Abstract presented at the 17th ISPD Congress. Vancouver (Canada). 2018. [P-229]

8 Firanek C, et al. A briefing was presented at the 54th ERA-EDTA Congress. Madrid (Spain). 2017. [MP557]

9 Joternand Draper V, et al. Perit Dial Int. 2018; 38 ፡777–78; 10. Rojas-Diaz M & Ramos A. Abstract presented at ASN Kidney Week Congress. New Orleans (USA) 2017. [TH-PO859]

10 Rivera A, et al. Presentation at the ASN Kidney Week Congress. San Diego (USA). 2018. [FR-PO683]

11 Rivara MB, Mehrotra R. Landscaping Change in the United States Landscape. Current opinion on nephrology and hypertension .2014; 23 (6): 586-591.doi: 10.1097 / MNH00000000000066; Mehrotra R, Chiu YW, Kalantar-Zadeh K, Bargman J, Vonesh E. Similar results in patients with end-stage renal disease in hemodialysis and peritoneal dialysis. Internal Medicine Records. 2011; 171 (2) ፡ 110-1118. Doe pick 10.1001 / archinternmed.2010.352; Ledebo I, Ronco C. The Best Dialysis Treatment? Results of an international survey of nephrologists. Transplantation of nephrological dialysis.2008; 6: 403-408. doi: 10.1093 / ndtplus / sfn148; Schiller B, Nitzer A, Dos S. Awareness among nephrologists about kidney transplant therapy. Nephrology News and Issues. September 2010; 36-44; Ghaffarri A, Kalantar-Zadeh K, Lee J, Maddux F, Moran J, Nissenson A. PD Initially clear peritoneal dialysis to dialysis treatment as default. Seminars in Dialysis. 2013; 26 (6) ፡c 706-713. doi: 10.1111 / sdi.12125.

12 Rubin HR et al. Patients’ dialysis rates with peritoneal dialysis vs hemodialysis. Jema. 2004 February 11; 291 (6): 697-703.

13 Juergensen, et al. Hemodialysis and Peritoneal Waste Condition – Assessing Patient Satisfaction with Medicine and the Impact of Treatment on Their Lives. Cline J. M. Sock Nefrol. 2006; 1 (6) ፡ 119 1191-1196.

14 Zazzeroni L HR et al. Comparing quality of life in patients with hemodialysis and peritoneal dialysis is a systematic review and meta-analysis. Renal hypertension. 2017; 42 (4): 717-727. USRDS ADR 2018 ፡ Tax Form 2 ESRD, Chapter 5; Figure 5.1.